Stock Agreements in the Pharmaceuticals Industry

1,867 Contracts & Agreements

Browse by Company

Acasti Pharma Inc. (7 contracts)
Accelerated Pharma, Inc. (1)
ACELRX PHARMACEUTICALS INC (10)
Acer Therapeutics Inc. (10)
ACHILLION PHARMACEUTICALS INC (7)
Aclaris Therapeutics, Inc. (6)
Acreage Holdings, Inc. (6)
ACURA PHARMACEUTICALS, INC (8)
Adamis Pharmaceuticals Corp (19)
ADIAL PHARMACEUTICALS, INC. (6)
Aegerion Pharmaceuticals, Inc. (18)
AEOLUS PHARMACEUTICALS, INC. (7)
AEON Biopharma, Inc. (1)
AERIE PHARMACEUTICALS INC (18)
Aerpio Pharmaceuticals, Inc. (7)
AGILE THERAPEUTICS INC (7)
Akers Biosciences, Inc. (7)
AKESIS PHARMACEUTICALS, INC. (10)
Akorn (15)
ALDER BIOPHARMACEUTICALS INC (7)
Alexza Pharmaceuticals Inc. (11)
ALGORX PHARMACEUTICALS INC (2)
ALIMERA SCIENCES INC (8)
Allergan, plc (1)
ALSERES PHARMACEUTICALS INC (15)
Altus Pharmaceuticals Inc. (9)
Amag Pharmaceuticals (36)
Amphastar Pharma (4)
Ampio Pharmaceuticals, Inc. (8)
AMYLIN PHARMACEUTICALS INC (7)
Amylyx Pharmaceuticals, Inc. (2)
AN2 Therapeutics, Inc. (3)
Anacor Pharmaceuticals, Inc. (3)
ANADYS PHARMACEUTICALS INC (2)
Anebulo Pharmaceuticals, Inc. (2)
Angion Biomedica Corp. (4)
ANGIOTECH PHARMACEUTICALS INC (3)
ANI Pharma Inc (12)
Anthera Pharmaceuticals Inc (6)
APP Pharmaceuticals, Inc. (1)
Applied BioSciences Corp. (3)
APRICUS BIOSCIENCES, INC. (9)
Aquestive Therapeutics, Inc. (5)
ARADIGM CORP (5)
Aralez Pharmaceuticals Inc. (5)
ARIAD PHARMACEUTICALS INC (13)
Arog Pharmaceuticals, Inc. (1)
ARTELO BIOSCIENCES, INC. (2)
Artemis Therapeutics, Inc. (9)
ARVINAS, INC. (4)
Assertio Therapeutics, Inc (13)
Astex Pharmaceuticals, Inc (2)
ATAI Life Sciences B.V. (9)
Atea Pharmaceuticals, Inc. (5)
Athira Pharma, Inc. (4)
Auspex Pharmaceuticals, Inc. (5)
AUXILIUM PHARMACEUTICALS INC (14)
AVADEL PHARMACEUTICALS PLC (3)
AVALON PHARMACEUTICALS INC (1)
AVANIR PHARMACEUTICALS, INC. (5)
AVENUE THERAPEUTICS, INC. (3)
AXIM BIOTECHNOLOGIES, INC. (6)
Axsome Therapeutics, Inc. (1)
AYTU BIOSCIENCE, INC (5)
Barrel Energy Inc. (1)
Baudax Bio, Inc. (3)
Bausch Health Companies Inc. (8)
BENTLEY PHARMACEUTICALS INC (1)
Bespoke Extracts, Inc. (2)
Big Rock Partners Acquisition Corp. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (10)
Biofrontera Inc. (3)
BioNumerik Pharmaceuticals, Inc. (8)
BioPharmX Corp (9)
Blue Water Acquisition Corp. (5)
BODY & MIND INC. (1)
Boston Therapeutics, Inc. (9)
Braeburn Pharmaceuticals, Inc. (1)
Bright Green Corp (1)
Bristol-Myers Squibb (8)
Canbiola, Inc. (9)
Cancer Prevention Pharmaceuticals, Inc. (6)
CANNAPHARMARX, INC. (1)
CANNAPOWDER, INC. (1)
Canopy Growth Corp (9)
Cara Therapeutics, Inc. (2)
CARDAX, INC. (6)
CASSAVA SCIENCES INC (4)
Catalent Inc (16)
Celator Pharmaceuticals Inc (2)
CELGENE CORP (1)
Cerecor Inc. (6)
Charlotte's Web Holdings, Inc. (1)
CHIASMA, INC (3)
CHINA PHARMA HOLDINGS, INC. (1)
China Yongxin Pharmaceuticals Inc. (1)
CinCor Pharma, Inc. (3)
Cingulate Inc. (5)
Citius Pharmaceuticals, Inc. (4)
Clearside Biomedical, Inc. (2)
Clever Leaves Holdings Inc. (4)
CLS Holdings USA, Inc. (2)
CNS Pharmaceuticals, Inc. (3)
Cocrystal Pharma, Inc. (6)
COGNITION THERAPEUTICS INC (5)
COLLAGENEX PHARMACEUTICALS INC (2)
COLLEGIUM PHARMACEUTICAL, INC (8)
CoLucid Pharmaceuticals, Inc. (3)
Columbia Care Inc. (3)
Context Therapeutics Inc. (3)
ContraVir Pharmaceuticals, Inc. (2)
Corcept Therapeutics Incorporated (6)
CorMedix Inc. (3)
CPEX Pharmaceuticals, Inc. (4)
Cronos Group Inc. (6)
CUBIST PHARMACEUTICALS INC (7)
CUMBERLAND PHARMACEUTICALS INC (6)
Cure Pharmaceutical Holding Corp. (2)
CymaBay Therapeutics, Inc. (3)
Cyteir Therapeutics, Inc. (2)
Dermata Therapeutics, Inc. (2)
DiCE MOLECULES HOLDINGS, LLC (2)
Dova Pharmaceuticals Inc. (2)
DURECT CORP (13)
Edgewise Therapeutics, Inc. (4)
Egalet Corp (8)
Elanco Animal Health Inc (11)
Eleison Pharmaceuticals Inc (1)
ELITE PHARMACEUTICALS INC (6)
Elixir Pharmaceuticals, Inc. (4)
Eloxx Pharmaceuticals, Inc. (13)
ENCYSIVE PHARMACEUTICALS INC (7)
Endo International plc (1)
Endo Pharmaceuticals Solutions Inc. (3)
EPIX Pharmaceuticals, Inc. (5)
Eton Pharmaceuticals, Inc. (4)
Evofem Biosciences, Inc. (13)
Evoke Pharma Inc (3)
Evolus, Inc. (7)
Exactus, Inc. (11)
EYEGATE PHARMACEUTICALS INC (4)
EYENOVIA, INC. (3)
EyePoint Pharmaceuticals, Inc. (10)
EYETECH PHARMACEUTICALS INC (6)
FRONTIER OILFIELD SERVICES INC (3)
Fulcrum Therapeutics, Inc. (3)
GENAISSANCE PHARMACEUTICALS INC (5)
GFR PHARMACEUTICALS INC (1)
GRAYBUG VISION, INC. (6)
GREEN HYGIENICS HOLDINGS INC. (2)
GridIron BioNutrients, Inc. (2)
Harmony Biosciences Holdings, Inc. (4)
HARROW HEALTH, INC. (10)
Haymaker Acquisition Corp. III (4)
HERATSI PHARMACEUTICALS (1)
Horizon Pharma plc (6)
Hoth Therapeutics, Inc. (3)
IDENIX PHARMACEUTICALS INC (5)
Ikena Oncology, Inc. (2)
IMARA Inc. (5)
INNOVATE BIOPHARMACEUTICALS, INC. (4)
Innoviva, Inc. (10)
INSPIRE PHARMACEUTICALS INC (10)
IntelGenx Technologies Corp. (4)
Intersect ENT, Inc. (4)
Intra-Cellular Therapies, Inc. (2)
ISTA PHARMACEUTICALS INC (6)
Jaguar Health, Inc. (18)
JAVELIN PHARMACEUTICALS, INC (3)
Jazz Pharmaceuticals plc (37)
Johnson & Johnson (5)
Journey Medical Corp (5)
JUNIPER PHARMACEUTICALS INC (3)
Jushi Holdings Inc. (7)
Kala Pharmaceuticals, Inc. (8)
Kaleido Biosciences, Inc. (2)
Kannalife Inc (1)
KEMPHARM, INC (4)
KING PHARMACEUTICALS INC (2)
Landos Biopharma, Inc. (2)
Lannett Company, Inc. (4)
Lev Pharmaceuticals Inc (2)
Level Brands, Inc. (1)
Lexaria Bioscience Corp. (16)
Lilly (Eli) & Co. (38)
LIPELLA PHARMACEUTICALS INC (3)
Lipocine Inc. (2)
Liquidia Corp (7)
Liquidia Technologies Inc (2)
Longboard Pharmaceuticals, Inc. (4)
Lyra Therapeutics, Inc. (4)
Mallinckrodt (4)
MAP Pharmaceuticals, Inc. (6)
Marijuana Co of America, Inc. (2)
MARINUS PHARMACEUTICALS INC (3)
MAXIM PHARMACEUTICALS INC (1)
Medicine Man Technologies, Inc. (10)
MEMORY PHARMACEUTICALS CORP (4)
Menlo Therapeutics Inc. (3)
Merck (2)
MICROCHANNEL TECHNOLOGIES CORP (7)
MiddleBrook Pharmaceuticals, Inc. (4)
Milestone Pharmaceuticals Inc. (3)
Mind Medicine (MindMed) Inc. (3)
MJ Holdings, Inc. (4)
Molecular Insight Pharmaceuticals, Inc. (6)
MYnd Analytics, Inc. (12)
MyoKardia Inc (3)
Mystic Holdings Inc. (1)
Nabriva Therapeutics plc (1)
NAREK PHARMACEUTICALS (1)
NEKTAR THERAPEUTICS (10)
Neos Therapeutics, Inc. (2)
Neuralstem, Inc. (12)
NewBridge Global Ventures, Inc. (8)
NGM BIOPHARMACEUTICALS INC (4)
NovaBay Pharmaceuticals, Inc. (8)
Novan, Inc. (8)
NOVEN PHARMACEUTICALS INC (7)
NPS PHARMACEUTICALS INC (13)
NUCRYST Pharmaceuticals Corp. (2)
OCULAR THERAPEUTIX, INC (7)
Odonate Therapeutics, Inc. (6)
OMEROS CORP (6)
Omthera Pharmaceuticals, Inc. (3)
OncoMed Pharmaceuticals Inc (2)
Onconova Therapeutics, Inc. (5)
ONYX PHARMACEUTICALS INC (2)
OPIANT PHARMACEUTICALS, INC. (1)
OPTIMER PHARMACEUTICALS INC (3)
OptiNose, Inc. (3)
ORAMED PHARMACEUTICALS INC. (8)
Organon & Co. (1)
OSI PHARMACEUTICALS INC (9)
OTONOMY, INC. (1)
Pacira Pharmaceuticals, Inc. (11)
Panacea Acquisition Corp (6)
PANACOS PHARMACEUTICALS, INC. (7)
Paratek Pharmaceuticals, Inc. (13)
PaxMedica, Inc. (2)
PENWEST PHARMACEUTICALS CO (3)
Perrigo (4)
Petros Pharmaceuticals, Inc. (3)
Pfizer (7)
PHARMOS CORP (1)
Phathom Pharmaceuticals, Inc. (3)
Phibro Animal Health Corporation (1)
Planet 13 Holdings Inc. (2)
PLAYERS NETWORK (10)
PLIANT THERAPEUTICS, INC. (2)
PLx Pharma Inc. (3)
PONIARD PHARMACEUTICALS, INC. (4)
PRAECIS PHARMACEUTICALS INC (1)
PREDIX PHARMACEUTICALS HOLDINGS INC (9)
Prestige Brands Holdings Inc (3)
Processa Pharmaceuticals, Inc. (2)
ProPhase Labs, Inc. (5)
PROTEO INC (7)
PROVECTUS BIOPHARMACEUTICALS, INC. (4)
Provention Bio, Inc. (2)
Pulmatrix, Inc. (3)
QUANTA INC (2)
QUARK PHARMACEUTICALS INC (18)
QUATRX PHARMACEUTICALS CO (3)
QUESTCOR PHARMACEUTICALS INC (1)
Ra Pharmaceuticals, Inc. (4)
RADIENT PHARMACEUTICALS Corp (8)
Rain Therapeutics Inc. (5)
Rani Therapeutics Holdings, Inc. (3)
REATA PHARMACEUTICALS INC (9)
Recro Pharma, Inc. (15)
Reliant Pharmaceuticals, Inc. (2)
RELMADA THERAPEUTICS, INC. (7)
RespireRx Pharmaceuticals Inc. (22)
resTORbio, Inc. (8)
Revance Therapeutics, Inc. (9)
Rib-X Pharmaceuticals, Inc. (4)
ROCK CREEK PHARMACEUTICALS, INC. (9)
Roivant Sciences Ltd. (2)
SALIX PHARMACEUTICALS LTD (7)
Satsuma Pharmaceuticals, Inc. (7)
SAVIENT PHARMACEUTICALS INC (9)
SCICLONE PHARMACEUTICALS INC (10)
Scopus BioPharma Inc. (2)
scPharmaceuticals Inc. (2)
SCYNEXIS INC (16)
Semnur Pharmaceuticals, Inc. (2)
SenesTech, Inc. (8)
Sienna Biopharmaceuticals, Inc. (1)
Sirtris Pharmaceuticals, Inc. (5)
Sonoma Pharmaceuticals, Inc. (12)
Strongbridge Biopharma plc (6)
Sucampo Pharmaceuticals, Inc. (3)
SUNWIN STEVIA INTERNATIONAL, INC. (5)
Supernus Pharmaceuticals, Inc. (5)
SYNERGY PHARMACEUTICALS, INC. (4)
Synovics Pharmaceuticals (2)
Target Group Inc. (1)
Tarsus Pharmaceuticals, Inc. (3)
TAURIGA SCIENCES, INC. (4)
Tenzing Acquisition Corp. (1)
Terns Pharmaceuticals, Inc. (4)
Terra Tech Corp. (24)
TETRAPHASE PHARMACEUTICALS INC (4)
TFF Pharmaceuticals, Inc. (2)
The Medicines Company (2)
TherapeuticsMD, Inc. (4)
Theseus Pharmaceuticals, Inc. (3)
TITAN PHARMACEUTICALS INC (11)
Trevi Therapeutics, Inc. (2)
Tribute Pharmaceuticals Canada Inc. (2)
Tricida, Inc. (7)
Trulieve Cannabis Corp. (5)
Urigen Pharmaceuticals, Inc. (1)
Urovant Sciences Ltd. (1)
VALEANT PHARMACEUTICALS INTERNATIONAL (1)
Valera Pharmaceuticals Inc (2)
Vallon Pharmaceuticals, Inc. (16)
Ventyx Biosciences, Inc. (5)
Verano Holdings Corp. (1)
VERBENA PHARMACEUTICALS INC (1)
Verrica Pharmaceuticals Inc. (5)
VIA Pharmaceuticals, Inc. (9)
Viamet Pharmaceuticals Holdings LLC (1)
VICURON PHARMACEUTICALS INC (2)
VioQuest Pharmaceuticals, Inc. (11)
Vireo Health International, Inc. (10)
Virpax Pharmaceuticals, Inc. (4)
Vitae Pharmaceuticals, Inc (6)
Vitality Biopharma, Inc. (4)
VIVUS INC (6)
WEED, INC. (2)
XANODYNE PHARMACEUTICALS INC (3)
XERIS PHARMACEUTICALS INC (2)
Zoetis (9)
ZOGENIX, INC. (4)
Zomedica Pharmaceuticals Corp. (8)
Zynerba Pharmaceuticals, Inc. (1)

Recent Contracts

Stock Purchase Agreement, dated December 19, 2024, among Aadi Bioscience, Inc., KAKEN INVESTMENTS INC., KAKEN PHARMACEUTICAL CO., LTD., and Aadi Subsidiary, Inc (Aerpio Pharmaceuticals, Inc., Filed With SEC on December 20, 2024)
Form of Common Stock Option Agreement for Independent Directors (PROVECTUS BIOPHARMACEUTICALS, INC., Filed With SEC on December 5, 2024)
Form of Common Stock Option Agreement for Officers (PROVECTUS BIOPHARMACEUTICALS, INC., Filed With SEC on December 5, 2024)
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement used in connection with the Aclaris Therapeutics, Inc. 2024 Inducement Plan (Aclaris Therapeutics, Inc., Filed With SEC on November 18, 2024)
Form of Stock Option Grant Notice and Stock Option Agreement used in connection with the Aclaris Therapeutics, Inc. 2024 Inducement Plan (Aclaris Therapeutics, Inc., Filed With SEC on November 18, 2024)
Form of Eyenovia, Inc. Inducement Stock Option Award Agreement (EYENOVIA, INC., Filed With SEC on November 12, 2024)
Stock Appreciation Rights Plan (Zomedica Pharmaceuticals Corp., Filed With SEC on November 7, 2024)
Stock Appreciation Rights Agreement (Directors) (Zomedica Pharmaceuticals Corp., Filed With SEC on November 7, 2024)
Stock Appreciation Rights Agreement (Employees) (Zomedica Pharmaceuticals Corp., Filed With SEC on November 7, 2024)
Form of Stock Option Cancellation Agreement (resTORbio, Inc., Filed With SEC on November 6, 2024)
Form of Stock Option Grant Notice and Form of Stock Option Agreement under 2024 Semnur Pharmaceuticals, Inc. Stock Option Plan (Semnur Pharmaceuticals, Inc., Filed With SEC on November 6, 2024)
2024 Semnur Pharmaceuticals, Inc. Stock Option Plan (Semnur Pharmaceuticals, Inc., Filed With SEC on November 6, 2024)
Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2014 Inducement Plan (Pacira Pharmaceuticals, Inc., Filed With SEC on November 6, 2024)
Form of Nonstatutory Stock Option Agreement under the Amended and Restated 2014 Inducement Plan (Pacira Pharmaceuticals, Inc., Filed With SEC on November 6, 2024)
Form of Stock Option Grant Notice and Stock Option Agreement under 2024 Inducement Plan (Verrica Pharmaceuticals Inc., Filed With SEC on November 4, 2024)
Form of Restricted Stock Unit Award Grant Notice and Award Agreement under 2024 Inducement Plan (Verrica Pharmaceuticals Inc., Filed With SEC on November 4, 2024)
Form of Amendment to Stock Option Agreement, dated October 16, 2024 (Eloxx Pharmaceuticals, Inc., Filed With SEC on October 17, 2024)
Form of Common Stock Certificate (Acasti Pharma Inc., Filed With SEC on October 7, 2024)
Stock Purchase Agreement, dated as of October 1, 2024, by and between TNF Pharmaceuticals, Inc. and Prevail Partners, LLC (Akers Biosciences, Inc., Filed With SEC on October 7, 2024)
Form of Restricted Stock Unit Agreement (AVENUE THERAPEUTICS, INC., Filed With SEC on September 27, 2024)
DURECT Corporation 2000 Stock Plan, as amended (DURECT CORP, Filed With SEC on September 26, 2024)
Common Stock Purchase Agreement by and among Liquidia Corporation and the Purchasers, dated September 10, 2024 (Liquidia Corp, Filed With SEC on September 12, 2024)
Form of Letter Agreement re Inducment Offer to Exercise Common Stock Purchase Warrants (PaxMedica, Inc., Filed With SEC on September 6, 2024)
Rights Agreement, dated as of August 15, 2024, between AN2 Therapeutics, Inc. and Equiniti Trust Company, LLC, which includes the Form of Certificate of Designations of Series A... (AN2 Therapeutics, Inc., Filed With SEC on August 19, 2024)
Stock Appreciation Rights Agreement (Directors) (Zomedica Pharmaceuticals Corp., Filed With SEC on August 14, 2024)
Stock Appreciation Rights Agreement (Employees) (Zomedica Pharmaceuticals Corp., Filed With SEC on August 14, 2024)
Amended and Restated 2002 Lilly Stock Plan (Lilly (Eli) & Co., Filed With SEC on August 8, 2024)
Form of Stock (Context Therapeutics Inc., Filed With SEC on August 7, 2024)
Form of Stock Option Agreement (Inducement Grant) of Context Therapeutics Inc (Context Therapeutics Inc., Filed With SEC on August 7, 2024)
Stock Purchase Agreement between CNS Pharmaceuticals, Inc. and Cortice Biosciences, Inc (CNS Pharmaceuticals, Inc., Filed With SEC on July 30, 2024)
Form of Employee Restricted Stock Unit Award Agreement for use with the DURECT Corporation 2000 Stock Plan (DURECT CORP, Filed With SEC on July 30, 2024)
Form of 2024 NSO Stock Option Award Agreement (Acasti Pharma Inc., Filed With SEC on June 27, 2024)
Form of 2024 ISO Stock Option Award Agreement (Acasti Pharma Inc., Filed With SEC on June 27, 2024)
Amended and Restated 2011 Employee Stock Purchase Plan (ACELRX PHARMACEUTICALS INC, Filed With SEC on June 24, 2024)
EyePoint Pharmaceuticals, Inc. Amendment No 2. to 2019 Employee Stock Purchase Plan (EyePoint Pharmaceuticals, Inc., Filed With SEC on June 21, 2024)
Evolus Inc. 2024 Employee Stock Purchase Plan (Evolus, Inc., Filed With SEC on June 11, 2024)
Description of Capital Stock of Canopy Growth Corporation (Canopy Growth Corp, Filed With SEC on May 30, 2024)
Amended 2022 Stock Plan, Form of Restricted Stock Grant Agreement (Employees) (ANI Pharma Inc, Filed With SEC on May 23, 2024)
Amended 2022 Stock Plan, Form of Restricted Stock Grant Agreement (Directors) (ANI Pharma Inc, Filed With SEC on May 23, 2024)
Stock Purchase Agreement, dated January 22, 2024, by and between Planet 13 Holdings Inc. and SGW FL Enterprises, LLC (Planet 13 Holdings Inc., Filed With SEC on May 7, 2024)